Microvast Holdings announces departure of chief financial officer
In a recent SEC filing, McCormick & Co Inc. (NYSE:MKC) director Maritza Gomez disclosed the sale of 5,912 shares of the company’s common stock on April 1, 2025. The shares were sold at an average price of $82.67, resulting in a total transaction value of approximately $488,745. Following this transaction, Gomez retains ownership of 6,938 shares of McCormick’s common stock.
Additionally, Gomez executed an option to acquire 5,912 shares at a price of $52.975 per share, a transaction valued at $313,188. However, the option exercise did not involve a purchase price, as noted in the filing. After these transactions, Gomez’s total holdings include 5,000 shares of non-voting common stock.
In other recent news, McCormick & Company reported mixed financial results for the first quarter of 2025. The company’s Consumer Segment saw a 16% decline in profit in constant currency terms, while the Flavor Solutions division showed a 3.3% organic sales growth. Bernstein analysts maintained an Outperform rating on McCormick, citing a potential reformulation supercycle in the U.S. packaged foods industry as a growth opportunity. However, Argus analysts downgraded McCormick’s stock from "Buy" to "Hold" due to concerns over rising costs and decreased restaurant foot traffic in key markets. Meanwhile, TD Cowen lowered its price target for McCormick to $90, maintaining a Buy rating, highlighting the company’s robust volume growth despite earnings falling short of expectations.
Additionally, Bernstein raised its price target for McCormick to $101, reflecting confidence in improved profit growth in upcoming quarters. McCormick’s recent acknowledgment of increased product reformulation activity aligns with Bernstein’s thesis of an emerging industry trend. The company also held its Annual Meeting of Stockholders, where shareholders approved executive compensation and elected eleven directors to the board. The appointment of Ernst & Young LLP as the independent auditor was confirmed, underscoring McCormick’s commitment to transparency and shareholder engagement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.